-
Something wrong with this record ?
Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia
L. Berec, M. Šmíd, L. Přibylová, O. Májek, T. Pavlík, J. Jarkovský, M. Zajíček, J. Weiner, T. Barusová, J. Trnka
Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-10-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- COVID-19 * prevention & control MeSH
- Hospitalization MeSH
- Humans MeSH
- Pandemics MeSH
- BNT162 Vaccine MeSH
- Vaccination MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.
1st Faculty of Medicine Charles University Praha Czech Republic
Centre for Modelling of Biological and Social Processes Praha Czech Republic
Czech Academy of Sciences Institute of Information Theory and Automation Praha Czech Republic
Department of Biochemistry Cell and Molecular Praha Czech Republic
Department of Mathematics and Statistics Faculty of Science Masaryk University Brno Czech Republic
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Health Information and Statistics of the Czech Republic Praha Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025253
- 003
- CZ-PrNML
- 005
- 20240117121204.0
- 007
- ta
- 008
- 221017s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0270801 $2 doi
- 035 __
- $a (PubMed)35802590
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Berec, Luděk $u Centre for Mathematical Biology, Institute of Mathematics, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic $u Department of Ecology, Czech Academy of Sciences, Biology Centre, Institute of Entomology, České Budějovice, Czech Republic $u Centre for Modelling of Biological and Social Processes, Praha, Czech Republic $1 https://orcid.org/0000000224193324
- 245 10
- $a Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia / $c L. Berec, M. Šmíd, L. Přibylová, O. Májek, T. Pavlík, J. Jarkovský, M. Zajíček, J. Weiner, T. Barusová, J. Trnka
- 520 9_
- $a Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.
- 650 _2
- $a vakcína BNT162 $7 D000090982
- 650 12
- $a COVID-19 $x prevence a kontrola $7 D000086382
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a vakcinace $7 D014611
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šmíd, Martin $u Centre for Modelling of Biological and Social Processes, Praha, Czech Republic $u Czech Academy of Sciences, Institute of Information Theory and Automation, Praha, Czech Republic
- 700 1_
- $a Přibylová, Lenka $u Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Májek, Ondřej $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic $1 https://orcid.org/0000000200343084
- 700 1_
- $a Pavlík, Tomáš $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic
- 700 1_
- $a Jarkovský, Jiří $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic
- 700 1_
- $a Zajíček, Milan, $u Czech Academy of Sciences, Institute of Information Theory and Automation, Praha, Czech Republic $d 1971- $7 ntka174464
- 700 1_
- $a Weiner, Jakub $u Centre for Modelling of Biological and Social Processes, Praha, Czech Republic $u Siesta Labs, Praha, Czech Republic
- 700 1_
- $a Barusová, Tamara $u First Faculty of Medicine, Charles University, Praha, Czech Republic $u Department of Statistical Modelling, Czech Academy of Sciences, Institute of Computer Science, Praha, Czech Republic $7 xx0312819
- 700 1_
- $a Trnka, Jan $u Department of Biochemistry, Cell and Molecular Praha, Czech Republic
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 17, č. 7 (2022), s. e0270801
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35802590 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20240117121200 $b ABA008
- 999 __
- $a ok $b bmc $g 1854782 $s 1176543
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 17 $c 7 $d e0270801 $e 20220708 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20221017